[{"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-001", "question": "A 5-week-old term infant presents with extreme irritability, brisk pupillary light reflexes, and episodic generalized hypertonia with arching of the back. There is reportedly bilious vomiting after feeds and undigested formula in loose stools. Testing reveals a severe hyponatremia (115 mEq/L), hypochloremia, and hyperkalemia with severe metabolic acidosis. Ultrasound shows bladder wall thickening with bilateral hydroureteronephrosis but no posterior urethral valves. Plasma renin activity is markedly elevated, and serum cortisol is normal. Which of the following electrolyte management strategies is most specifically appropriate pending definitive diagnosis?", "options": ["Isotonic saline boluses followed by fluid restriction to prevent sodium loss", "Hypertonic saline with sodium polystyrene sulfonate and sodium bicarbonate", "Isotonic saline with fludrocortisone to promote renal sodium reabsorption", "Normal saline boluses and maintenance fluids with added sodium bicarbonate and potassium chloride", "Withhold all sodium and potassium, provide glucose-only intravenous fluids to minimize tubular electrolyte load"], "answer": "B", "answer_index": 1, "explanation": "This infant has classic pseudohypoaldosteronism type 1 (autosomal recessive multiple organ form) due to mutations in the epithelial sodium channel (ENaC) subunits. The key is severe renal salt-wasting with hyperkalemia and metabolic acidosis despite elevated aldosterone/renin. Correction requires hypertonic saline for severe hyponatremia, sodium polystyrene sulfonate for hyperkalemia, and sodium bicarbonate for acidosis. Fludrocortisone is ineffective since the defect is in the aldosterone receptor/target. Saline alone worsens potassium and acidosis; glucose-only fluids would exacerbate hyponatremia and shock.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues driving a unique best answer: severe hyponatremia (115 mEq/L) with neurologic symptoms (irritability, hypertonia), hyperkalemia, metabolic acidosis, markedly elevated renin with normal cortisol, and bladder wall thickening with hydroureteronephrosis—classic for systemic pseudohypoaldosteronism type 1 (ENaC mutation). Option B is uniquely appropriate as it simultaneously addresses all three life-threatening derangements: hypertonic saline for severe symptomatic hyponatremia, sodium polystyrene sulfonate for hyperkalemia, and sodium bicarbonate for metabolic acidosis. Alternative options are definitively incorrect: A's fluid restriction worsens hyponatremia; C's fludrocortisone is ineffective in systemic PHA1; D adds potassium to hyperkalemia; E withholds needed sodium. No logical issues exist—single best answer is clear. Minor medical accuracy note: sodium polystyrene sulfonate is generally avoided in neonates due to NEC risk, but the question's strategic focus is sound. No fix required.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues driving a unique best answer: severe hyponatremia (115 mEq/L) with neurologic symptoms (irritability, hypertonia), hyperkalemia, metabolic acidosis, markedly elevated renin with normal cortisol, and bladder wall thickening with hydroureteronephrosis—classic for systemic pseudohypoaldosteronism type 1 (ENaC mutation). Option B is uniquely appropriate as it simultaneously addresses all three life-threatening derangements: hypertonic saline for severe symptomatic hyponatremia, sodium polystyrene sulfonate for hyperkalemia, and sodium bicarbonate for metabolic acidosis. Alternative options are definitively incorrect: A's fluid restriction worsens hyponatremia; C's fludrocortisone is ineffective in systemic PHA1; D adds potassium to hyperkalemia; E withholds needed sodium. No logical issues exist—single best answer is clear. Minor medical accuracy note: sodium polystyrene sulfonate is generally avoided in neonates due to NEC risk, but the question's strategic focus is sound. No fix required.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-002", "question": "A previously healthy 3-year-old boy is admitted with acute liver failure of unknown etiology. He develops progressive ascites, coagulopathy, and encephalopathy. While awaiting transplantation evaluation, he becomes increasingly tachycardic and hypotensive. Echocardiography shows a hyperdynamic left ventricle, increased cardiac output, and a dilated inferior vena cava with minimal respiratory variation. Pulmonary capillary wedge pressure is 6 mmHg, systemic vascular resistance is markedly low. Terlipressin is initiated but the child develops profound peripheral cyanosis and worsening respiratory distress. Which of the following is the most appropriate next step in management?", "options": ["Increase terlipressin dose and add IV norepinephrine", "Immediately stop terlipressin and start IV epoprostenol", "Stop terlipressin and initiate IV methylene blue bolus followed by infusion", "Perform emergent transjugular intrahepatic portosystemic shunt (TIPS)", "Add IV octreotide and midodrine while continuing terlipressin"], "answer": "C", "answer_index": 2, "explanation": "This patient has developed hepatopulmonary syndrome (HPS) with profound intrapulmonary shunting, worsened by terlipressin-induced pulmonary vasoconstriction. Methylene blue inhibits nitric oxide-mediated vasodilation, improving hypoxemia and hemodynamics in HPS. Continuing terlipressin or adding norepinephrine exacerbates pulmonary hypertension and shunt. Epoprostenol worsens hypotension and shunting. TIPS is contraindicated in acute liver failure with encephalopathy. Octreotide/midodrine are ineffective for HPS and may worsen splanchnic ischemia.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: U (Underspecified). The stem lacks objective evidence of hepatopulmonary syndrome (HPS) (e.g., arterial blood gas, contrast echocardiography) and does not differentiate HPS from other causes of cyanosis such as pulmonary hypertension or ARDS. Consequently, the answer choices, which target HPS, require an unstated assumption that HPS is present. Verdict: Not uniquely determinable. Key clues (hyperdynamic LV, low SVR, dilated IVC, cyanosis after terlipressin) suggest distributive shock but fail to confirm HPS. Main logical issue: missing critical diagnostic detail, making the item underspecified. Main medical accuracy issue: the rationale incorrectly attributes worsening HPS to terlipressin (a vasoconstrictor that may actually improve HPS) and recommends methylene blue, an experimental therapy lacking pediatric evidence and not endorsed by major guidelines. Minimal fix: add a sentence confirming HPS (e.g., 'Contrast echo shows delayed left‑atrial bubble passage indicating intrapulmonary shunting') and replace the key with a standard vasopressor regimen (e.g., start norepinephrine) or remove the experimental option.\",\n\"medical_accuracy_score\":   \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"U\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified). The stem lacks objective evidence of hepatopulmonary syndrome (HPS) (e.g., arterial blood gas, contrast echocardiography) and does not differentiate HPS from other causes of cyanosis such as pulmonary hypertension or ARDS. Consequently, the answer choices, which target HPS, require an unstated assumption that HPS is present. Verdict: Not uniquely determinable. Key clues (hyperdynamic LV, low SVR, dilated IVC, cyanosis after terlipressin) suggest distributive shock but fail to confirm HPS. Main logical issue: missing critical diagnostic detail, making the item underspecified. Main medical accuracy issue: the rationale incorrectly attributes worsening HPS to terlipressin (a vasoconstrictor that may actually improve HPS) and recommends methylene blue, an experimental therapy lacking pediatric evidence and not endorsed by major guidelines. Minimal fix: add a sentence confirming HPS (e.g., 'Contrast echo shows delayed left‑atrial bubble passage indicating intrapulmonary shunting') and replace the key with a standard vasopressor regimen (e.g., start norepinephrine) or remove the experimental option.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-003", "question": "A 34-year-old woman presents to the ED 48 hours after a mountain climbing expedition above 18,000 feet. She reports severe headache, ataxia, and intermittent confusion. She was placed on high-flow oxygen, given dexamethasone 10 mg IV, and planned for descent. While awaiting helicopter transport, she develops sudden-onset facial droop, right hemiparesis, and global aphasia. Vital signs: BP 158/92, HR 110, SpO2 92% on 15L non-rebreather (previously 82%). Non-contrast head CT is normal. Which of the following is the most appropriate immediate therapeutic intervention?", "options": ["Administer IV tissue plasminogen activator (tPA) per stroke protocol", "Hyperbaric oxygen therapy in a portable chamber at the current altitude", "Immediate rapid descent to below 8,000 feet while maintaining oxygen", "Initiate IV heparin for presumed cerebral venous sinus thrombosis", "Increase dexamethasone to 20 mg IV and add acetazolamide 500 mg IV"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-altitude cerebral edema (HACE) with focal neurological deficits mimicking stroke, likely from venous infarction or hemorrhage. At this extreme altitude, hyperbaric oxygen immediately reduces intracranial pressure while awaiting evacuation. tPA is contraindicated due to potential hemorrhagic component and unclear time of symptom onset. Descent is critical but will take time; in-transport hyperbaric therapy provides immediate benefit. Heparin risks hemorrhage in HACE. Increased steroids and acetazolamide are inadequate for acute deterioration with focal deficits.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. The stem establishes HACE with acute neurological deterioration at extreme altitude where descent is delayed awaiting helicopter transport. Hyperbaric oxygen therapy is the most immediately available intervention that directly addresses HACE pathophysiology. While focal deficits raise stroke consideration, the normal CT, extreme altitude context, and explicit rationale framing this as HACE progression with possible venous infarction make hyperbaric O2 the unique best answer. Descent remains definitive but is not immediately executable; tPA is contraindicated due to hemorrhage risk and unclear onset; heparin risks bleeding; steroids/acetazolamide are insufficient for acute deterioration. Verdict: Correct best answer. Key clues: >18,000 ft altitude, established HACE diagnosis, sudden focal deficits after initial therapy, normal CT, awaiting helicopter transport. Logical issues: None significant; item requires accepting that \\\"immediate\\\" refers to what is executable on-site. Medical issues: Focal deficits are atypical for pure HACE, but wilderness medicine literature supports hyperbaric O2 for severe HACE with neurological compromise when descent is delayed. Minimal fix: Specify \\\"descent by foot is impossible due to terrain and weather, making helicopter evacuation the only descent option\\\" to remove any ambiguity about immediacy of descent.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. The stem establishes HACE with acute neurological deterioration at extreme altitude where descent is delayed awaiting helicopter transport. Hyperbaric oxygen therapy is the most immediately available intervention that directly addresses HACE pathophysiology. While focal deficits raise stroke consideration, the normal CT, extreme altitude context, and explicit rationale framing this as HACE progression with possible venous infarction make hyperbaric O2 the unique best answer. Descent remains definitive but is not immediately executable; tPA is contraindicated due to hemorrhage risk and unclear onset; heparin risks bleeding; steroids/acetazolamide are insufficient for acute deterioration. Verdict: Correct best answer. Key clues: >18,000 ft altitude, established HACE diagnosis, sudden focal deficits after initial therapy, normal CT, awaiting helicopter transport. Logical issues: None significant; item requires accepting that \"immediate\" refers to what is executable on-site. Medical issues: Focal deficits are atypical for pure HACE, but wilderness medicine literature supports hyperbaric O2 for severe HACE with neurological compromise when descent is delayed. Minimal fix: Specify \"descent by foot is impossible due to terrain and weather, making helicopter evacuation the only descent option\" to remove any ambiguity about immediacy of descent.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-004", "question": "A 32-year-old G2P1001 at 31 weeks gestation presents with acute-onset severe abdominal pain and hypotension. Ultrasound shows a normal intrauterine pregnancy with fetal heart rate 140 bpm, but a large right adnexal complex mass with free fluid. She is taken emergently to OR for suspected ovarian torsion. Intraoperatively, the right ovary is necrotic and detorted but appears hemorrhagic with surface excrescences. Frozen section returns 'atypical cells, cannot rule out malignancy.' Which of the following is the most appropriate surgical management?", "options": ["Right oophorectomy only, preserve uterus and left adnexa", "Right oophorectomy with right pelvic lymph node sampling", "Right oophorectomy with infracolic omentectomy and pelvic washings", "Right salpingo-oophorectomy with left ovarian biopsy and appendectomy", "Proceed with total abdominal hysterectomy with bilateral salpingo-oophorectomy"], "answer": "C", "answer_index": 2, "explanation": "In pregnancy with suspected ovarian cancer, staging should be as complete as possible while preserving the pregnancy. Omentectomy and washings provide critical staging information without compromising uterine blood supply or requiring extensive dissection near the gravid uterus. Lymph node sampling is not recommended in pregnancy due to risk of hemorrhage near iliac vessels; full lymphadenectomy can wait until postpartum. Appendectomy is only indicated for mucinous tumors. Hysterectomy terminates pregnancy unnecessarily; ovarian biopsy of normal ovary is not indicated. Frozen section limitations necessitate complete staging for definitive management decisions.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: Correct best answer. Key stem clues: 31-week viable gestation, necrotic hemorrhagic ovary with excrescences, indeterminate frozen section. The clinical problem is balancing oncologic staging with pregnancy preservation. Option C (right oophorectomy + infracolic omentectomy + pelvic washings) is uniquely defensible: it obtains critical staging data via safe, pregnancy-sparing procedures while avoiding risky lymphadenectomy near iliac vessels (ruling out B) and unnecessary hysterectomy (ruling out E). Option A provides no staging when malignancy is possible; D adds unwarranted left ovarian biopsy and appendectomy without mucinous histology. No logical flaws: the stem supplies sufficient discriminating detail, options are mutually exclusive, and the key aligns with current guidelines for suspected ovarian cancer in pregnancy (avoid nodal dissection, defer hysterectomy, stage with washings/omentectomy). Medical accuracy is sound: infracolic omentectomy is feasible at 31 weeks, and rationale correctly notes lymph node sampling risks and appendectomy's limited indication. Minor nuance: frozen-section limitations are realistic but could be expanded. Minimal fix: specify 'suspected epithelial ovarian cancer' in stem to solidify rationale for omentectomy over appendectomy.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: 31-week viable gestation, necrotic hemorrhagic ovary with excrescences, indeterminate frozen section. The clinical problem is balancing oncologic staging with pregnancy preservation. Option C (right oophorectomy + infracolic omentectomy + pelvic washings) is uniquely defensible: it obtains critical staging data via safe, pregnancy-sparing procedures while avoiding risky lymphadenectomy near iliac vessels (ruling out B) and unnecessary hysterectomy (ruling out E). Option A provides no staging when malignancy is possible; D adds unwarranted left ovarian biopsy and appendectomy without mucinous histology. No logical flaws: the stem supplies sufficient discriminating detail, options are mutually exclusive, and the key aligns with current guidelines for suspected ovarian cancer in pregnancy (avoid nodal dissection, defer hysterectomy, stage with washings/omentectomy). Medical accuracy is sound: infracolic omentectomy is feasible at 31 weeks, and rationale correctly notes lymph node sampling risks and appendectomy's limited indication. Minor nuance: frozen-section limitations are realistic but could be expanded. Minimal fix: specify 'suspected epithelial ovarian cancer' in stem to solidify rationale for omentectomy over appendectomy.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-005", "question": "A 42-year-old man with treatment-resistant schizophrenia on clozapine 450 mg daily develops acute urinary retention and obtundation. He was recently started on diphenhydramine 50 mg nightly for insomnia. In the ED, temperature is 38.9°C, HR 128, BP 168/102. He is diaphoretic, rigid, and incontinent of urine with myoclonus. Creatine kinase is 12,000 U/L, white count 18,000/mm³. After stopping all medications, which of the following is the most specific initial treatment?", "options": ["IV dantrolene 2.5 mg/kg", "IV bromocriptine 2.5 mg three times daily", "Oral cyproheptadine 12 mg loading dose", "IV physostigmine 1-2 mg", "IV lorazepam 2 mg every hour"], "answer": "D", "answer_index": 3, "explanation": "This is anticholinergic delirium with clozapine-diphenhydramine toxicity mimicking neuroleptic malignant syndrome (NMS). Physostigmine reverses central anticholinergic toxicity and helps differentiate from NMS. Dantrolene is for malignant hyperthermia, not anticholinergic crisis. Bromocriptine may worsen psychosis and is ineffective for anticholinergic toxicity. Cyproheptadine is for serotonin syndrome. Lorazepam addresses agitation but doesn't reverse anticholinergic blockade. The urinary retention, myoclonus, and recent antihistamine addition suggest anticholinergic crisis rather than pure NMS, though clozapine can cause both.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). The vignette describes fever, rigidity, diaphoresis, autonomic instability, CK 12,000 U/L, and leukocytosis in a clozapine-treated patient—classic neuroleptic malignant syndrome (NMS). While diphenhydramine adds anticholinergic burden (urinary retention, myoclonus), rigidity and severe CK elevation are not features of anticholinergic toxicity and definitively indicate NMS. The rationale's framing as 'anticholinergic delirium mimicking NMS' is incorrect; these are not mimickers but diagnostic criteria. Therefore, the most specific treatment should target NMS (bromocriptine or dantrolene), not anticholinergic toxicity. Physostigmine is ineffective for NMS and potentially unsafe. The keyed answer (D) is thus misaligned with the stem's dominant syndrome. Alternatives A and B are appropriate NMS therapies; E is supportive. Medical accuracy is compromised by conflating distinct toxidromes. Fix: Remove rigidity and reduce CK to <1,000 U/L to support pure anticholinergic toxicity, or change key to bromocriptine with NMS-focused rationale.\",\"medical_accuracy_score\":  \t\"2\",\"logical_validity\": false,\"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). The vignette describes fever, rigidity, diaphoresis, autonomic instability, CK 12,000 U/L, and leukocytosis in a clozapine-treated patient—classic neuroleptic malignant syndrome (NMS). While diphenhydramine adds anticholinergic burden (urinary retention, myoclonus), rigidity and severe CK elevation are not features of anticholinergic toxicity and definitively indicate NMS. The rationale's framing as 'anticholinergic delirium mimicking NMS' is incorrect; these are not mimickers but diagnostic criteria. Therefore, the most specific treatment should target NMS (bromocriptine or dantrolene), not anticholinergic toxicity. Physostigmine is ineffective for NMS and potentially unsafe. The keyed answer (D) is thus misaligned with the stem's dominant syndrome. Alternatives A and B are appropriate NMS therapies; E is supportive. Medical accuracy is compromised by conflating distinct toxidromes. Fix: Remove rigidity and reduce CK to <1,000 U/L to support pure anticholinergic toxicity, or change key to bromocriptine with NMS-focused rationale.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-006", "question": "A 28-year-old woman with borderline personality disorder presents after ingesting 100 tablets of acetaminophen 500 mg. She presents 30 hours post-ingestion with normal vital signs and normal mental status. AST is 850 U/L, INR is 1.8, creatinine is 1.2 mg/dL. IV N-acetylcysteine (NAC) is initiated. Six hours into the infusion, she develops acute respiratory distress, wheezing, facial edema, and hypotension. After stopping NAC and administering diphenhydramine and methylprednisolone, her symptoms resolve. Her AST has risen to 2,100 U/L. Which of the following is the most appropriate next step?", "options": ["Continue NAC at a reduced rate with diphenhydramine premedication", "Switch to oral NAC 140 mg/kg followed by 70 mg/kg every 4 hours", "Begin high-flux hemodialysis to remove acetaminophen and NAC", "Administer cimetidine 300 mg IV every 6 hours as NAC alternative", "Initiate IV L-ornithine L-aspartate and silibinin as hepatoprotective agents"], "answer": "B", "answer_index": 1, "explanation": "Oral NAC is equally effective as IV for acetaminophen toxicity and should be used when IV causes anaphylactoid reactions. Continuing IV NAC with premedication risks recurrent reaction and hypotension. Hemodialysis does not effectively remove acetaminophen or NAC metabolites. Cimetidine has limited evidence and insufficient hepatoprotection. L-ornithine and silibinin are unproven in acute overdose. Since the patient presented late with established hepatotoxicity, completion of NAC via oral route is critical for glutathione repletion despite initial reaction to IV formulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette presents a clear, clinically coherent scenario: a severe anaphylactoid reaction to IV NAC in a patient with established acetaminophen-induced hepatotoxicity 30 hours after ingesting 50g. Key discriminating findings include the timing (late presentation with AST 2,100 U/L and INR 1.8 indicating significant liver injury), the severity of the infusion reaction (hypotension, respiratory distress, facial edema), and the necessity to complete a full NAC course for glutathione repletion. The keyed answer B—switching to standard oral NAC protocol (140 mg/kg load, then 70 mg/kg q4h)—is uniquely defensible and represents established toxicology practice for IV NAC intolerance. Alternative A is unsafe given the severe reaction; rechallenge risks recurrent anaphylactoid shock. Option C is inappropriate as hemodialysis does not effectively remove acetaminophen or NAC metabolites at this stage and is not indicated. Options D and E are incorrect: cimetidine has no proven role as NAC alternative, and L-ornithine/silibinin are specific for amanita poisoning, not acetaminophen toxicity. The item contains no contradictions or critical omissions, and all options permit clear discrimination. Medical accuracy is consistent with AASLD/ACMT guidelines. No revision needed.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette presents a clear, clinically coherent scenario: a severe anaphylactoid reaction to IV NAC in a patient with established acetaminophen-induced hepatotoxicity 30 hours after ingesting 50g. Key discriminating findings include the timing (late presentation with AST 2,100 U/L and INR 1.8 indicating significant liver injury), the severity of the infusion reaction (hypotension, respiratory distress, facial edema), and the necessity to complete a full NAC course for glutathione repletion. The keyed answer B—switching to standard oral NAC protocol (140 mg/kg load, then 70 mg/kg q4h)—is uniquely defensible and represents established toxicology practice for IV NAC intolerance. Alternative A is unsafe given the severe reaction; rechallenge risks recurrent anaphylactoid shock. Option C is inappropriate as hemodialysis does not effectively remove acetaminophen or NAC metabolites at this stage and is not indicated. Options D and E are incorrect: cimetidine has no proven role as NAC alternative, and L-ornithine/silibinin are specific for amanita poisoning, not acetaminophen toxicity. The item contains no contradictions or critical omissions, and all options permit clear discrimination. Medical accuracy is consistent with AASLD/ACMT guidelines. No revision needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-007", "question": "A 65-year-old man with major depressive disorder and chronic back pain develops serotonin syndrome after starting tramadol. He is managed with discontinuation of serotonergic agents and supportive care. One week later, he develops acute severe myoclonus, rigidity, hyperthermia (40.2°C), and autonomic instability. He had been started on olanzapine 5 mg daily four days prior for agitation. Creatine kinase is 25,000 U/L. Which of the following pathophysiological mechanisms best explains this paradoxical deterioration?", "options": ["Dopamine receptor upregulation causing rebound hyperdopaminergic state", "Serotonin transporter internalization leading to synaptic serotonin accumulation", "Gamma-aminobutyric acid (GABA) depletion from prolonged muscle activity", "Malignant catatonia triggered by antipsychotic withdrawal", "N-methyl-D-aspartate (NMDA) receptor hypofunction secondary to serotonin depletion"], "answer": "E", "answer_index": 4, "explanation": "This represents the serotonin syndrome-neuroleptic malignant syndrome (NMS) overlap or 'serotonin-NMS syndrome' where serotonin depletion following serotonin syndrome predisposes to NMDA receptor hypofunction, creating vulnerability to NMS when antipsychotics are introduced. Dopamine upregulation doesn't occur this rapidly. Serotonin transporter internalization would reduce, not increase, serotonin. GABA depletion is not a recognized mechanism. Malignant catatonia typically evolves more slowly. The sequence of serotonin syndrome followed by antipsychotic exposure with severe hyperthermia and rigidity suggests NMDA hypofunction as the bridge between these syndromes.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Keyed answer is the best among options but reflects a non-standard mechanism. Key clues: prior serotonin syndrome, new-onset rigidity/hyperthermia/CK 25,000 after olanzapine initiation, suggesting neuroleptic malignant syndrome (NMS). The question seeks a mechanism linking these events. Options A-D are clearly incorrect: dopamine upregulation is wrong direction and timeframe; serotonin transporter internalization would reduce synaptic serotonin; GABA depletion is not a recognized NMS mechanism; malignant catatonia is a syndrome, not mechanism, and triggered by withdrawal not initiation. Option E proposes NMDA receptor hypofunction from serotonin depletion as the bridge. However, this mechanism is not widely accepted in mainstream literature. The established NMS mechanism is dopamine D2 receptor antagonism from antipsychotics. While serotonin syndrome may predispose to NMS, the proposed NMDA link is speculative and not standard board-level knowledge. This represents a major medical inaccuracy. Minimal fix: Replace option E with 'Dopamine D2 receptor antagonism in basal ganglia and hypothalamus' and adjust key accordingly.\",\"medical_accuracy_score\":   \"2\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Keyed answer is the best among options but reflects a non-standard mechanism. Key clues: prior serotonin syndrome, new-onset rigidity/hyperthermia/CK 25,000 after olanzapine initiation, suggesting neuroleptic malignant syndrome (NMS). The question seeks a mechanism linking these events. Options A-D are clearly incorrect: dopamine upregulation is wrong direction and timeframe; serotonin transporter internalization would reduce synaptic serotonin; GABA depletion is not a recognized NMS mechanism; malignant catatonia is a syndrome, not mechanism, and triggered by withdrawal not initiation. Option E proposes NMDA receptor hypofunction from serotonin depletion as the bridge. However, this mechanism is not widely accepted in mainstream literature. The established NMS mechanism is dopamine D2 receptor antagonism from antipsychotics. While serotonin syndrome may predispose to NMS, the proposed NMDA link is speculative and not standard board-level knowledge. This represents a major medical inaccuracy. Minimal fix: Replace option E with 'Dopamine D2 receptor antagonism in basal ganglia and hypothalamus' and adjust key accordingly.", "medical_accuracy_score": 2, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-008", "question": "A 58-year-old man undergoes robotic-assisted laparoscopic prostatectomy for Gleason 4+3=7 adenocarcinoma. On postoperative day 2, he develops abdominal distension and ileus. CT scan demonstrates a 3 cm retroperitoneal urinoma at the vesicourethral anastomosis. A percutaneous drain is placed, output is 200 mL/day of urine. After two weeks, drain output remains 150 mL/day despite Foley catheter drainage. Retrograde cystogram shows no leak. Which of the following is the most appropriate intervention to achieve closure?", "options": ["Prolonged Foley catheter drainage for 4-6 weeks", "Endoscopic placement of double-J ureteral stent", "Percutaneous nephrostomy tube placement", "Endoscopic injection of fibrin glue at anastomotic site", "Surgical revision of vesicourethral anastomosis"], "answer": "A", "answer_index": 0, "explanation": "For persistent urinoma after prostatectomy with no evidence of active leak on cystogram, the urinoma represents a 'urinoma cavity' that must collapse and seal. Prolonged Foley drainage (4-6 weeks) allows gradual collapse and healing. Ureteral stent or nephrostomy diverts urine but doesn't address the dead space. Fibrin glue injection risks infection and rarely works for established cavities. Surgical revision carries high morbidity and is rarely needed for small persistent drainage. The key is recognizing that low-output drainage from a drain may represent residual cavity fluid rather than active leak, requiring time rather than invasive intervention.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem establishes a post-prostatectomy urinoma with persistent low-output drainage (150 mL/day) despite catheter drainage, but critically, a negative retrograde cystogram. This key finding excludes an active anastomotic leak, reframing the problem as a residual non-communicating cavity requiring collapse rather than leak closure. Prolonged Foley decompression (Option A) is the standard conservative management, reducing intravesical pressure to allow healing. Alternative options are appropriately inferior: ureteral stents (B) and nephrostomy (C) divert proximal urine but do not address a bladder-neck dead space; fibrin glue (D) lacks evidence and risks infection for established cavities; surgical revision (E) is excessive morbidity for a small, non-leaking collection. The item is logically sound with a single best answer driven by the cystogram result. Medical accuracy is consistent with urologic consensus favoring extended catheterization for low-output urinomas without demonstrable extravasation. Minor nuance: the term 'urine' output could be clarified as 'fluid' since cystogram shows no leak, but this does not impair answer selection. No revision required.\",\"medical_accuracy_score\":   \t\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem establishes a post-prostatectomy urinoma with persistent low-output drainage (150 mL/day) despite catheter drainage, but critically, a negative retrograde cystogram. This key finding excludes an active anastomotic leak, reframing the problem as a residual non-communicating cavity requiring collapse rather than leak closure. Prolonged Foley decompression (Option A) is the standard conservative management, reducing intravesical pressure to allow healing. Alternative options are appropriately inferior: ureteral stents (B) and nephrostomy (C) divert proximal urine but do not address a bladder-neck dead space; fibrin glue (D) lacks evidence and risks infection for established cavities; surgical revision (E) is excessive morbidity for a small, non-leaking collection. The item is logically sound with a single best answer driven by the cystogram result. Medical accuracy is consistent with urologic consensus favoring extended catheterization for low-output urinomas without demonstrable extravasation. Minor nuance: the term 'urine' output could be clarified as 'fluid' since cystogram shows no leak, but this does not impair answer selection. No revision required.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-009", "question": "A 45-year-old woman with neurofibromatosis type 1 presents with progressive paraparesis over 3 months. MRI shows a large enhancing intradural extramedullary mass at T4-T7 displacing the spinal cord, with multiple neuroforaminal extensions. During resection, the tumor is found to be highly vascular and adherent to multiple nerve roots. Intraoperative monitoring shows loss of motor evoked potentials (MEPs) in the lower extremities after partial debulking. Which of the following is the most appropriate intraoperative response?", "options": ["Abort surgery and close; plan for postoperative stereotactic radiosurgery", "Continue resection; MEP loss may be temporary with tumor manipulation", "Administer high-dose methylprednisolone and continue with subtotal resection", "Obtain immediate intraoperative frozen section to rule out malignant transformation", "Switch to intracapsular ultrasonic aspiration to minimize nerve root traction"], "answer": "A", "answer_index": 0, "explanation": "In spinal schwannomas (common in NF1), persistent loss of MEPs during resection indicates significant spinal cord ischemia or injury, likely from vascular compromise of the anterior spinal artery via tumor feeders. Continuing risks permanent paraplegia. Temporary MEP changes typically recover within minutes; persistent loss mandates stopping. Steroids are inadequate for vascular injury. Frozen section doesn't change acute management. Ultrasonic aspiration still risks vascular injury. The appropriate approach is to stop, preserve neurological function, and use stereotactic radiosurgery for residual tumor, which is effective for schwannomas and avoids surgical morbidity.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: U (Underspecified). Verdict: Not uniquely determinable. The stem describes a NF1 patient with a vascular intradural extramedullary spinal tumor and intraoperative MEP loss. Key discriminating clues include the NF1 association, tumor location, vascularity, and new MEP loss after debulking. The critical missing detail is whether MEP loss is persistent or temporary. Without specifying persistence, both A (abort) and B (continue, may be temporary) are defensible. In practice, temporary loss from manipulation can recover within minutes, but the stem provides no timeline or signal recovery information. This underspecification prevents a single best answer. Medical accuracy issue: the rationale incorrectly states schwannomas are common in NF1; neurofibromas are the hallmark spinal tumor in NF1, while schwannomas characterize NF2. This misstatement doesn't alter the core principle that persistent MEP loss warrants aborting, but it reflects inaccurate tumor biology. The management principle itself is sound—continuing resection after persistent MEP loss risks permanent paraplegia, and SRS is appropriate for residual tumor. Minimal fix: Insert 'persistent' before 'loss of motor evoked potentials' to clarify the scenario and justify aborting surgery.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\": false,\"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). Verdict: Not uniquely determinable. The stem describes a NF1 patient with a vascular intradural extramedullary spinal tumor and intraoperative MEP loss. Key discriminating clues include the NF1 association, tumor location, vascularity, and new MEP loss after debulking. The critical missing detail is whether MEP loss is persistent or temporary. Without specifying persistence, both A (abort) and B (continue, may be temporary) are defensible. In practice, temporary loss from manipulation can recover within minutes, but the stem provides no timeline or signal recovery information. This underspecification prevents a single best answer. Medical accuracy issue: the rationale incorrectly states schwannomas are common in NF1; neurofibromas are the hallmark spinal tumor in NF1, while schwannomas characterize NF2. This misstatement doesn't alter the core principle that persistent MEP loss warrants aborting, but it reflects inaccurate tumor biology. The management principle itself is sound—continuing resection after persistent MEP loss risks permanent paraplegia, and SRS is appropriate for residual tumor. Minimal fix: Insert 'persistent' before 'loss of motor evoked potentials' to clarify the scenario and justify aborting surgery.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-010", "question": "A 72-year-old man with Gleason 4+5=9 adenocarcinoma of the prostate, cT3bN1M0, completes definitive intensity-modulated radiation therapy (IMRT) to prostate and pelvis to 79.2 Gy with 2 years of androgen deprivation therapy (ADT). Six months after completing ADT, PSA rises to 5.2 ng/mL. Ga-68 PSMA PET/CT shows isolated PSMA-avid retroperitoneal lymph node measuring 1.8 cm at the aortocaval confluence, SUVmax 12.5. Which of the following represents the most appropriate definitive management?", "options": ["Salvage extended field radiotherapy to include the retroperitoneum", "Systemic therapy with enzalutamide or abiraterone", "Metastasis-directed stereotactic body radiotherapy (SBRT) to the involved node", "Retroperitoneal lymph node dissection", "Re-initiation of ADT with docetaxel chemotherapy"], "answer": "C", "answer_index": 2, "explanation": "For oligorecurrent prostate cancer with a single PSMA-avid node, metastasis-directed therapy with SBRT offers durable control with minimal toxicity compared to systemic therapy or extended field RT. The STOMP and ORIOLE trials support this approach. Extended field radiotherapy to abdomen would have significant bowel toxicity. Systemic therapy is premature for solitary metastasis. Retroperitoneal lymph node dissection carries morbidity and may not be curative. Re-initiating ADT with chemotherapy is overtreatment for oligometastatic disease. SBRT provides local control while delaying systemic therapy and its side effects.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. This vignette describes oligorecurrent prostate cancer with a single PSMA-avid retroperitoneal node after definitive chemoradiation. Key discriminating findings: isolated 1.8 cm node on PSMA PET, PSA 5.2 ng/mL six months post-ADT, high-risk initial disease. The evidence base (STOMP, ORIOLE trials) and current guidelines support metastasis-directed SBRT for true oligometastatic recurrence to delay systemic therapy and improve outcomes. Option C is uniquely defensible: SBRT provides local control with minimal toxicity. Option A (extended field RT) is inferior due to excessive bowel toxicity. Option B (systemic therapy) is premature for solitary disease. Option D (retroperitoneal lymph node dissection) carries higher morbidity than SBRT without proven superiority. Option E (ADT + docetaxel) is overtreatment; docetaxel is reserved for high-volume metastatic disease. No internal contradictions; all options are plausible but clearly inferior. Medical accuracy is excellent: aligns with EAU/NCCN recommendations for oligometastatic prostate cancer. The item is board-relevant and clinically realistic. Minimal fix: none required; item is robust as written.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. This vignette describes oligorecurrent prostate cancer with a single PSMA-avid retroperitoneal node after definitive chemoradiation. Key discriminating findings: isolated 1.8 cm node on PSMA PET, PSA 5.2 ng/mL six months post-ADT, high-risk initial disease. The evidence base (STOMP, ORIOLE trials) and current guidelines support metastasis-directed SBRT for true oligometastatic recurrence to delay systemic therapy and improve outcomes. Option C is uniquely defensible: SBRT provides local control with minimal toxicity. Option A (extended field RT) is inferior due to excessive bowel toxicity. Option B (systemic therapy) is premature for solitary disease. Option D (retroperitoneal lymph node dissection) carries higher morbidity than SBRT without proven superiority. Option E (ADT + docetaxel) is overtreatment; docetaxel is reserved for high-volume metastatic disease. No internal contradictions; all options are plausible but clearly inferior. Medical accuracy is excellent: aligns with EAU/NCCN recommendations for oligometastatic prostate cancer. The item is board-relevant and clinically realistic. Minimal fix: none required; item is robust as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-011", "question": "A 9-month-old exclusively breastfed infant presents with severe metabolic acidosis (pH 7.18), lactic acidosis, hyperammonemia (250 μmol/L), and hypoglycemia. Urine organic acids show elevated 3-hydroxyisovalerylcarnitine, 3-methylglutaconate, and 3-hydroxy-3-methylglutarate. Plasma acylcarnitine profile reveals elevated C5-OH. The infant develops acute neurological deterioration with abnormal eye movements. Which of the following is the most urgent specific intervention?", "options": ["IV carnitine 100 mg/kg", "IV riboflavin 100 mg", "IV biotin 10 mg", "Oral glycine 250 mg/kg", "IV sodium benzoate 250 mg/kg"], "answer": "C", "answer_index": 2, "explanation": "The biochemical profile indicates multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). Biotin is the cofactor for all four carboxylases, and high-dose IV biotin can rapidly reverse the metabolic crisis. Carnitine may help with secondary deficiency but doesn't address the primary defect. Riboflavin is for multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II). Glycine is for isovaleric acidemia. Sodium benzoate is for hyperammonemia but does not correct carboxylase deficiency. The neurological symptoms may include seizures and coma requiring emergent biotin administration before confirmatory enzyme testing.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues: 9-month-old with metabolic crisis (pH 7.18, lactic acidosis, NH4+ 250 μmol/L, hypoglycemia) plus pathognomonic urine organic acids (3-hydroxyisovalerylcarnitine, 3-methylglutaconate, 3-hydroxy-3-methylglutarate) and plasma C5-OH elevation uniquely identify multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). The question asks for the most urgent *specific* intervention, not just supportive care. Biotin 10 mg IV directly corrects the primary enzymatic defect and is recommended before confirmatory testing in acute crisis. Alternative analysis: Carnitine (A) only addresses secondary deficiency; riboflavin (B) treats multiple acyl-CoA dehydrogenase deficiency; glycine (D) treats isovaleric acidemia; sodium benzoate (E) bypasses hyperammonemia but does not correct the carboxylase block. All distractors are appropriately tied to distinct metabolic disorders, permitting clear discrimination. No logical flaws: single best answer is defensible, key matches, no contradictions. Medical accuracy is gold-standard: metabolite pattern, pathophysiology, and emergent biotin therapy align precisely with current ACMG guidelines. Dose is appropriate for acute crisis. Minimal fix: None required; item is board-ready.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: 9-month-old with metabolic crisis (pH 7.18, lactic acidosis, NH4+ 250 μmol/L, hypoglycemia) plus pathognomonic urine organic acids (3-hydroxyisovalerylcarnitine, 3-methylglutaconate, 3-hydroxy-3-methylglutarate) and plasma C5-OH elevation uniquely identify multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). The question asks for the most urgent *specific* intervention, not just supportive care. Biotin 10 mg IV directly corrects the primary enzymatic defect and is recommended before confirmatory testing in acute crisis. Alternative analysis: Carnitine (A) only addresses secondary deficiency; riboflavin (B) treats multiple acyl-CoA dehydrogenase deficiency; glycine (D) treats isovaleric acidemia; sodium benzoate (E) bypasses hyperammonemia but does not correct the carboxylase block. All distractors are appropriately tied to distinct metabolic disorders, permitting clear discrimination. No logical flaws: single best answer is defensible, key matches, no contradictions. Medical accuracy is gold-standard: metabolite pattern, pathophysiology, and emergent biotin therapy align precisely with current ACMG guidelines. Dose is appropriate for acute crisis. Minimal fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-012", "question": "A 4-year-old boy with DiGeorge syndrome (22q11.2 deletion) develops pneumonia requiring hospitalization. He has previously undergone complete repair of tetralogy of Fallot and receives supplemental calcium and vitamin D for hypoparathyroidism. During hospitalization, he develops refractory hypocalcemia (ionized calcium 0.8 mmol/L) despite IV calcium gluconate. ECG shows prolonged QTc interval. Parathyroid hormone is undetectable. Which of the following electrolyte abnormalities most likely explains the calcium refractory to therapy?", "options": ["Hypomagnesemia (0.9 mg/dL)", "Hyperphosphatemia (8.2 mg/dL)", "Metabolic alkalosis (pH 7.48)", "Hyperkalemia (6.2 mEq/L)", "Hyponatremia (125 mEq/L)"], "answer": "A", "answer_index": 0, "explanation": "In DiGeorge syndrome with hypoparathyroidism, refractory hypocalcemia is most commonly due to hypomagnesemia, as magnesium is required for PTH secretion and end-organ response. Magnesium deficiency impairs both PTH release (already absent here) and the ability of administered PTH/calcium to maintain calcium levels. Hyperphosphatemia can lower calcium but doesn't cause refractoriness to IV calcium. Alkalosis increases protein binding but not true refractoriness. Hyperkalemia and hyponatremia don't directly affect calcium responsiveness. Magnesium repletion must precede effective calcium management in this setting.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. This item tests the principle that hypomagnesemia causes refractory hypocalcemia. Key stem clues: DiGeorge syndrome with hypoparathyroidism (undetectable PTH), refractory hypocalcemia despite IV calcium gluconate, prolonged QTc. The question asks which electrolyte abnormality explains refractoriness to therapy. Hypomagnesemia (0.9 mg/dL) impairs PTH end-organ response and calcium homeostasis at the cellular level, making IV calcium ineffective. While the rationale's mention of 'PTH secretion' is moot given undetectable PTH, the end-organ resistance mechanism remains valid and is the established basis for this clinical pearl. Alternative options are inferior: hyperphosphatemia can complex calcium but doesn't primarily cause refractoriness; alkalosis affects protein binding but ionized calcium is already measured; hyperkalemia and hyponatremia are irrelevant. No logical flaws or contradictions exist. Medical accuracy is sound: magnesium deficiency is the classic reversible cause of refractory hypocalcemia, and the scenario is realistic for a DiGeorge patient. Minimal fix: Revise rationale to emphasize end-organ resistance and calcium channel function rather than PTH secretion, which is already maximally suppressed.\",\"medical_accuracy_score\":   \t\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. This item tests the principle that hypomagnesemia causes refractory hypocalcemia. Key stem clues: DiGeorge syndrome with hypoparathyroidism (undetectable PTH), refractory hypocalcemia despite IV calcium gluconate, prolonged QTc. The question asks which electrolyte abnormality explains refractoriness to therapy. Hypomagnesemia (0.9 mg/dL) impairs PTH end-organ response and calcium homeostasis at the cellular level, making IV calcium ineffective. While the rationale's mention of 'PTH secretion' is moot given undetectable PTH, the end-organ resistance mechanism remains valid and is the established basis for this clinical pearl. Alternative options are inferior: hyperphosphatemia can complex calcium but doesn't primarily cause refractoriness; alkalosis affects protein binding but ionized calcium is already measured; hyperkalemia and hyponatremia are irrelevant. No logical flaws or contradictions exist. Medical accuracy is sound: magnesium deficiency is the classic reversible cause of refractory hypocalcemia, and the scenario is realistic for a DiGeorge patient. Minimal fix: Revise rationale to emphasize end-organ resistance and calcium channel function rather than PTH secretion, which is already maximally suppressed.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-013", "question": "A 19-year-old competitive free-diver presents to the ED 60 minutes after a 45-meter dive. He developed chest pain and hemoptysis upon surfacing. He is tachycardic, hypotensive, and hypoxic. Chest CT shows bilateral ground-glass opacities and pneumomediastinum. He is intubated for worsening hypoxia. During mechanical ventilation, he develops sudden cardiovascular collapse with pulseless electrical activity. Which of the following is the most appropriate immediate intervention?", "options": ["Needle decompression of both chests", "Initiating venoarterial extracorporeal membrane oxygenation (ECMO)", "Immediate hyperbaric oxygen therapy", "Administering IV epinephrine 1 mg", "Performing pericardiocentesis"], "answer": "B", "answer_index": 1, "explanation": "This diver has arterial gas embolism (AGE) with catastrophic decompression sickness. Cardiovascular collapse in AGE represents massive air in coronary or cerebral arteries. ECMO provides immediate cardiopulmonary support while allowing time for bubble resolution and prevents further air aspiration during chest compressions. Needle decompression is for tension pneumothorax, not AGE. Hyperbaric oxygen is definitive but cannot be performed during cardiac arrest. Epinephrine may worsen air trapping through bronchodilation. Pericardiocentesis is not indicated without pericardial effusion. ECMO is increasingly used in diving-related catastrophic AGE as a bridge to hyperbaric treatment.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: U (Underspecified). Verdict: Keyed answer not uniquely determinable. The stem describes a free-diver with pulmonary barotrauma (pneumomediastinum, hemoptysis) who arrests with PEA during ventilation. Critical missing detail: availability of immediate ECMO cannulation, which is not standard ED equipment. While ECMO is reported as rescue therapy for AGE, it cannot be initiated during ongoing CPR in most settings, making standard ACLS (epinephrine) the truly immediate intervention. The rationale incorrectly states epinephrine worsens air trapping and conflates free-diving with 'decompression sickness'—a pathophysiology error, as breath-hold divers do not absorb inert gas loads. This mischaracterization undermines the premise. Options A/E are correctly excluded, but C is impossible during arrest, leaving B vs D. Without specifying a tertiary ECMO-capable center, the question forces an unstated resource assumption that violates typical exam constraints. Minimal fix: Change 'free-diver' to 'scuba diver' and add 'at an ECMO-capable center' to the stem, or replace B with a more universally available intervention.\", \"medical_accuracy_score\":     \t\"2\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). Verdict: Keyed answer not uniquely determinable. The stem describes a free-diver with pulmonary barotrauma (pneumomediastinum, hemoptysis) who arrests with PEA during ventilation. Critical missing detail: availability of immediate ECMO cannulation, which is not standard ED equipment. While ECMO is reported as rescue therapy for AGE, it cannot be initiated during ongoing CPR in most settings, making standard ACLS (epinephrine) the truly immediate intervention. The rationale incorrectly states epinephrine worsens air trapping and conflates free-diving with 'decompression sickness'—a pathophysiology error, as breath-hold divers do not absorb inert gas loads. This mischaracterization undermines the premise. Options A/E are correctly excluded, but C is impossible during arrest, leaving B vs D. Without specifying a tertiary ECMO-capable center, the question forces an unstated resource assumption that violates typical exam constraints. Minimal fix: Change 'free-diver' to 'scuba diver' and add 'at an ECMO-capable center' to the stem, or replace B with a more universally available intervention.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-014", "question": "A 28-year-old G2P0010 at 7 weeks gestation presents with vaginal bleeding and lower abdominal pain. Quantitative β-hCG is 850 mIU/mL. Transvaginal ultrasound shows no intrauterine gestational sac, normal bilateral ovaries, and minimal free fluid in the cul-de-sac. Two days later, repeat β-hCG is 1,100 mIU/mL. Diagnostic laparoscopy reveals a 1 cm blue-bulge on the left fallopian tube consistent with ectopic pregnancy. Which of the following is the most appropriate management?", "options": ["Systemic methotrexate (MTX) 50 mg/m²", "Salpingostomy with preservation of the fallopian tube", "Segmental resection of the affected tubal portion", "Salpingectomy", "Expectant management with weekly β-hCG monitoring"], "answer": "D", "answer_index": 3, "explanation": "For ectopic pregnancy with β-hCG <2000 and small size, MTX is usually first-line. However, this patient has already undergone diagnostic laparoscopy, making surgical management more appropriate than switching to medical therapy. Given she is G2P0 with no living children, preservation might be considered, but studies show similar future fertility with salpingectomy versus salpingostomy, and salpingectomy eliminates risk of persistent ectopic tissue. Segmental resection is for isthmic ectopics when anastomosis is planned. Expectant management is inappropriate with visualized ectopic. Salpingostomy carries 5-20% risk of persistent trophoblast requiring additional treatment. Salpingectomy provides definitive treatment during the established surgical encounter.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible), secondary U (Underspecified). Verdict: Not uniquely determinable. Key stem clues: G2P0010 (no living children, desires fertility), small unruptured ectopic, β-hCG <2,000, diagnostic laparoscopy performed. These features drive a choice between fertility-preserving salpingostomy (B) and definitive salpingectomy (D). Main logical issue: Missing contralateral tube status creates ambiguity; both options are equally defensible depending on unstated assumptions about future fertility impact. The patient is nulliparous, making fertility preservation paramount, yet the rationale dismisses this without evidence. Main medical accuracy issue: Rationale oversimplifies fertility outcomes, misrepresenting guideline consensus that favors salpingostomy for nulliparous patients when technically feasible. The claim of equivalent fertility is not universally accepted and contradicts standard teaching that tube preservation benefits future pregnancy rates. Minimal fix: Add 'contralateral fallopian tube appears normal' to laparoscopic findings to justify salpingectomy, or 'contralateral tube is absent' to justify salpingostomy. This single detail would clarify whether tube preservation is essential for future fertility.\",\"medical_accuracy_score\":   \t\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible), secondary U (Underspecified). Verdict: Not uniquely determinable. Key stem clues: G2P0010 (no living children, desires fertility), small unruptured ectopic, β-hCG <2,000, diagnostic laparoscopy performed. These features drive a choice between fertility-preserving salpingostomy (B) and definitive salpingectomy (D). Main logical issue: Missing contralateral tube status creates ambiguity; both options are equally defensible depending on unstated assumptions about future fertility impact. The patient is nulliparous, making fertility preservation paramount, yet the rationale dismisses this without evidence. Main medical accuracy issue: Rationale oversimplifies fertility outcomes, misrepresenting guideline consensus that favors salpingostomy for nulliparous patients when technically feasible. The claim of equivalent fertility is not universally accepted and contradicts standard teaching that tube preservation benefits future pregnancy rates. Minimal fix: Add 'contralateral fallopian tube appears normal' to laparoscopic findings to justify salpingectomy, or 'contralateral tube is absent' to justify salpingostomy. This single detail would clarify whether tube preservation is essential for future fertility.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-015", "question": "A 55-year-old woman with treatment-resistant depression has been stable on phenelzine 60 mg daily for 3 years. She presents with acute confusion, fever (39.4°C), hypertonia, and myoclonus after starting amitriptyline 50 mg daily for neuropathic pain 5 days ago. Creatine kinase is 3,500 U/L. After discontinuing amitriptyline and providing supportive care, she develops persistent paranoid delusions and auditory hallucinations. Which of the following antipsychotics carries the LOWEST risk of precipitating serotonin syndrome or hypertensive crisis in this patient?", "options": ["Haloperidol", "Olanzapine", "Quetiapine", "Aripiprazole", "Brexpiprazole"], "answer": "C", "answer_index": 2, "explanation": "Quetiapine has the lowest serotonin reuptake inhibition among antipsychotics, minimizing serotonin syndrome risk when used with MAOIs. Haloperidol has minimal serotonergic effects but high dopamine blockade risks exacerbating parkinsonism after recent serotonin syndrome. Olanzapine has moderate serotonin 5-HT2A antagonism but minimal reuptake inhibition. Aripiprazole and brexpiprazole are partial agonists at 5-HT1A receptors and antagonists at 5-HT2A, with complex serotonergic profiles that could theoretically interact. Quetiapine's metabolite norquetiapine has norepinephrine reuptake inhibition but at therapeutic doses this is minimal. The priority is avoiding serotonergic agents while managing psychosis in a patient on irreversible MAOI.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: Haloperidol (A), not quetiapine (C), carries the lowest serotonergic risk. Key discriminating clues: chronic phenelzine therapy, recent life-threatening serotonin syndrome, and need for emergent psychosis management without triggering serotonergic toxicity. The keyed answer relies on a flawed premise that quetiapine has 'lowest serotonin reuptake inhibition'—a property negligible in most antipsychotics. Haloperidol is a butyrophenone with virtually no serotonergic activity, making it pharmacologically the safest regarding serotonin syndrome risk. The rationale's speculative concern about 'exacerbating parkinsonism' is unsupported and introduces an unstated clinical assumption not requested by the stem. This mischaracterization renders the item miskeyed. Medical accuracy score: 2 due to major pharmacologic error in justification. Minimal fix: Re-key to A, or revise stem to ask for the 'most appropriate' agent balancing serotonergic safety with tolerability, thereby justifying quetiapine based on lower extrapyramidal risk.\",\"medical_accuracy_score\":  \t\"2\",\"logical_validity\": false,\"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: Haloperidol (A), not quetiapine (C), carries the lowest serotonergic risk. Key discriminating clues: chronic phenelzine therapy, recent life-threatening serotonin syndrome, and need for emergent psychosis management without triggering serotonergic toxicity. The keyed answer relies on a flawed premise that quetiapine has 'lowest serotonin reuptake inhibition'—a property negligible in most antipsychotics. Haloperidol is a butyrophenone with virtually no serotonergic activity, making it pharmacologically the safest regarding serotonin syndrome risk. The rationale's speculative concern about 'exacerbating parkinsonism' is unsupported and introduces an unstated clinical assumption not requested by the stem. This mischaracterization renders the item miskeyed. Medical accuracy score: 2 due to major pharmacologic error in justification. Minimal fix: Re-key to A, or revise stem to ask for the 'most appropriate' agent balancing serotonergic safety with tolerability, thereby justifying quetiapine based on lower extrapyramidal risk.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-016", "question": "A 23-year-old woman with schizoaffective disorder, bipolar type, maintained on lithium 900 mg daily and paliperidone 6 mg daily, presents with 2 days of worsening confusion, ataxia, and tremors. Serum lithium is 3.2 mEq/L (toxic). She is treated with saline diuresis and recovers. Two weeks later, she is readmitted with recurrence of severe lithium toxicity (level 3.5 mEq/L) despite taking only prescribed lithium. Renal function is normal. Which of the following medication interactions most likely explains the recurrent toxicity?", "options": ["Paliperidone inhibiting renal tubular secretion of lithium", "Undiagnosed nephrogenic diabetes insipidus causing dehydration", "Nonsteroidal anti-inflammatory drug use reducing lithium clearance", "Thiazide diuretic prescribed for pedal edema", "Lithium tablet malabsorption with erratic bioavailability"], "answer": "D", "answer_index": 3, "explanation": "Thiazide diuretics cause sodium depletion, increasing renal lithium reabsorption and dramatically elevating serum levels, even with previously stable dosing. The time course fits with recent thiazide prescription after initial hospitalization. NSAIDs also reduce lithium clearance but typically less dramatically. Paliperidone has no known effect on lithium handling. Nephrogenic DI causes polyuria but not necessarily toxicity unless dehydration occurs. Malabsorption would lower, not increase, levels. Thiazides are often prescribed for lithium-induced edema or hypertension, creating this dangerous interaction that must be avoided in lithium-treated patients.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"The stem asks which medication interaction explains recurrent lithium toxicity with normal renal function. Key discriminating clues are the 2-week interval and phrase 'despite taking only prescribed lithium,' which is ambiguous about new prescriptions. The keyed answer D (thiazide diuretic) is medically sound—thiazides increase lithium reabsorption via sodium depletion and are a classic cause of toxicity. However, the stem fails to mention thiazide initiation or pedal edema, making the item underspecified (U). Answering requires assuming a thiazide was prescribed after discharge. Option C (NSAIDs) is also a plausible interaction without this information. While all options reflect accurate pharmacology (paliperidone lacks interaction, nephrogenic DI requires dehydration, malabsorption would lower levels), the missing detail prevents unique answer selection. Verdict: Not uniquely determinable. Minimal fix: Add explicit statement: 'She was started on hydrochlorothiazide 25 mg daily one week ago for new-onset pedal edema.'\",\"medical_accuracy_score\":   \"4\",\"logical_validity\": false,\"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The stem asks which medication interaction explains recurrent lithium toxicity with normal renal function. Key discriminating clues are the 2-week interval and phrase 'despite taking only prescribed lithium,' which is ambiguous about new prescriptions. The keyed answer D (thiazide diuretic) is medically sound—thiazides increase lithium reabsorption via sodium depletion and are a classic cause of toxicity. However, the stem fails to mention thiazide initiation or pedal edema, making the item underspecified (U). Answering requires assuming a thiazide was prescribed after discharge. Option C (NSAIDs) is also a plausible interaction without this information. While all options reflect accurate pharmacology (paliperidone lacks interaction, nephrogenic DI requires dehydration, malabsorption would lower levels), the missing detail prevents unique answer selection. Verdict: Not uniquely determinable. Minimal fix: Add explicit statement: 'She was started on hydrochlorothiazide 25 mg daily one week ago for new-onset pedal edema.'", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-017", "question": "A 32-year-old man with borderline intellectual functioning presents with new-onset complex motor tics, coprolalia, and obsessive-compulsive symptoms. He had group A streptococcal pharyngitis 6 weeks prior. Anti-streptolysin O titer is 800 IU/mL. MRI brain shows increased T2 signal in basal ganglia. Which of the following immunomodulatory therapies has demonstrated efficacy in controlled trials for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)?", "options": ["Intravenous immunoglobulin (IVIG)", "Plasmapheresis", "Oral penicillin prophylaxis", "Intravenous methylprednisolone", "Rituximab"], "answer": "A", "answer_index": 0, "explanation": "While evidence for PANDAS treatments is limited, the randomized controlled trial by Perlmutter et al. (1999) in Lancet demonstrated that IVIG and plasmapheresis were superior to placebo for symptom reduction. IVIG is generally preferred first-line due to lower morbidity than plasmapheresis. Oral penicillin prevents new streptococcal infections but doesn't treat active neuropsychiatric symptoms. IV steroids have anecdotal support but no controlled trial evidence. Rituximab has case reports but no controlled trials. The question specifies proven efficacy in controlled trials, making IVIG (and plasmapheresis) correct, but IVIG is more commonly used as initial immunomodulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: C (Contradiction); secondary M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable due to internal inconsistency. Key stem clues: 32-year-old adult patient contradicts \\\"pediatric\\\" disorder definition; complex motor tics, coprolalia, OCD; GAS infection 6 weeks prior; ASO titer 800 IU/mL; basal ganglia T2 hyperintensity. Main logical issue: Fundamental contradiction between patient age (32 years) and PANDAS definition (pediatric). Additionally, both IVIG and plasmapheresis meet the explicit selection criterion of \\\"demonstrated efficacy in controlled trials\\\" per Perlmutter et al. (1999), creating two defensible answers. The rationale acknowledges both are correct but selects A based on unstated practical considerations rather than the question's stated standard. Main medical accuracy issue: PANDAS is restricted to pediatric populations per diagnostic criteria; adult-onset post-streptococcal neuropsychiatric symptoms are not PANDAS. While treatment data for children is accurate, applying it to an adult without qualification is clinically invalid. Minimal fix: Change patient age to 8-12 years and revise question stem to \\\"Which is the generally preferred first-line immunomodulatory therapy...\\\" or remove plasmapheresis from options.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\": false,\"logical_false_reason\": \"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction); secondary M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable due to internal inconsistency. Key stem clues: 32-year-old adult patient contradicts \"pediatric\" disorder definition; complex motor tics, coprolalia, OCD; GAS infection 6 weeks prior; ASO titer 800 IU/mL; basal ganglia T2 hyperintensity. Main logical issue: Fundamental contradiction between patient age (32 years) and PANDAS definition (pediatric). Additionally, both IVIG and plasmapheresis meet the explicit selection criterion of \"demonstrated efficacy in controlled trials\" per Perlmutter et al. (1999), creating two defensible answers. The rationale acknowledges both are correct but selects A based on unstated practical considerations rather than the question's stated standard. Main medical accuracy issue: PANDAS is restricted to pediatric populations per diagnostic criteria; adult-onset post-streptococcal neuropsychiatric symptoms are not PANDAS. While treatment data for children is accurate, applying it to an adult without qualification is clinically invalid. Minimal fix: Change patient age to 8-12 years and revise question stem to \"Which is the generally preferred first-line immunomodulatory therapy...\" or remove plasmapheresis from options.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-018", "question": "A 65-year-old man with recurrent high-grade non-muscle invasive bladder cancer (pT1G3) refractory to BCG and pembrolizumab undergoes radical cystoprostatectomy with ileal conduit. Pathology shows pT2aN0 disease. Six months postoperatively, surveillance CT reveals a 2.5 cm enhancing mass at the left ureteroileal anastomosis. Cystoscopy confirms extrinsic compression. Biopsy shows recurrent urothelial carcinoma. Which of the following management approaches is most appropriate?", "options": ["Systemic chemotherapy with gemcitabine and cisplatin", "Radiation therapy to the anastomotic bed", "Surgical resection with revision of ureteroileal anastomosis", "Intravesical BCG instillation via conduit", "Enfortumab vedotin or sacituzumab govitecan"], "answer": "B", "answer_index": 1, "explanation": "Isolated local recurrence after radical cystectomy with negative margins is rare but potentially curable with radiation therapy. Surgical revision risks extensive adhesions and may not achieve clear margins. Systemic chemotherapy is indicated for metastatic disease but overtreats isolated local recurrence. Intravesical therapy cannot reach the ureteroileal anastomosis. Antibody-drug conjugates like enfortumab are for metastatic disease post-chemo and immunotherapy. Radiation with curative intent (60-66 Gy) offers chance of durable local control without morbidity of reoperation, particularly in medically inoperable patients or those with challenging surgical anatomy.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: U leading to M. Verdict: Not uniquely determinable. Key stem clues: isolated 2.5 cm ureteroileal anastomotic recurrence 6 months post-cystectomy, pT2aN0 original disease, prior BCG/pembrolizumab failure. The stem lacks critical information about surgical candidacy, extent of adhesions, or resectability that would favor radiation (Option B) over surgical revision (Option C). Both B and C are defensible best answers: radiation offers local control without operative morbidity, while surgery provides potential cure for resectable disease. The rationale assumes medical inoperability not stated. Options A, D, and E are appropriately excluded: systemic chemotherapy and ADCs overtreat isolated local disease, and intravesical BCG cannot reach the anastomosis. Main logical issue: underspecified stem creates equally weighted alternatives. Main medical accuracy issue: presenting radiation as definitively superior to surgery misrepresents guideline-based practice, where surgical excision is often preferred for resectable isolated recurrences. Minimal fix: Add phrase 'in a medically inoperable patient' to the stem to justify radiation as the most appropriate approach.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U leading to M. Verdict: Not uniquely determinable. Key stem clues: isolated 2.5 cm ureteroileal anastomotic recurrence 6 months post-cystectomy, pT2aN0 original disease, prior BCG/pembrolizumab failure. The stem lacks critical information about surgical candidacy, extent of adhesions, or resectability that would favor radiation (Option B) over surgical revision (Option C). Both B and C are defensible best answers: radiation offers local control without operative morbidity, while surgery provides potential cure for resectable disease. The rationale assumes medical inoperability not stated. Options A, D, and E are appropriately excluded: systemic chemotherapy and ADCs overtreat isolated local disease, and intravesical BCG cannot reach the anastomosis. Main logical issue: underspecified stem creates equally weighted alternatives. Main medical accuracy issue: presenting radiation as definitively superior to surgery misrepresents guideline-based practice, where surgical excision is often preferred for resectable isolated recurrences. Minimal fix: Add phrase 'in a medically inoperable patient' to the stem to justify radiation as the most appropriate approach.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-019", "question": "A 62-year-old man with metastatic renal cell carcinoma to L3 vertebra develops rapidly progressive cauda equina syndrome. He undergoes emergent L3 laminectomy with tumor debulking and posterior instrumentation. Postoperatively, he is unable to void and has perianal anesthesia. MRI shows residual tumor compressing the thecal sac. He is started on dexamethasone and referred for radiation oncology consultation. Which of the following radiotherapy parameters is most critical for optimizing neurological recovery while minimizing toxicity?", "options": ["Total dose of 30 Gy in 10 fractions", "Treatment volume limited to involved vertebral body only", "Omitting simultaneous integrated boost to macroscopic disease", "Avoiding concurrent vascular endothelial growth factor (VEGF) inhibitors", "Delaying radiotherapy until 4 weeks postoperatively"], "answer": "A", "answer_index": 0, "explanation": "For metastatic spinal cord compression with residual tumor post-decompression, 30 Gy in 10 fractions is the standard dose providing optimal balance of tumor control and spinal cord tolerance. Larger volumes including entire involved vertebra plus one above/below are needed to cover microscopic disease. Simultaneous boost increases cord toxicity risk. VEGF inhibitors can continue but with dose reduction if concurrent. Delaying radiation beyond 2 weeks increases recurrence risk; ideally start within 7-10 days postoperatively. The total dose-fractionation is most critical as single-fraction (8 Gy) provides less durable control, while higher doses (≥37.5 Gy) increase myelopathy risk without proven benefit.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). The question asks which radiotherapy parameter is most critical for optimizing neurological recovery while minimizing toxicity after emergent decompression for metastatic spinal cord compression. The stem provides key details: residual tumor compressing the thecal sac, postoperative deficits, and need for radiotherapy. The correct answer, A (30 Gy in 10 fractions), is the standard dose-fractionation that balances tumor control with spinal cord tolerance, as supported by major guidelines (e.g., NCCN, ASTRO). The alternative choices are clearly inferior: B (limited volume) would miss microscopic disease; C (omitting boost) is not the most critical factor; D (avoiding VEGF inhibitors) is unnecessary because these agents can be continued with dose adjustment; and E (delaying radiation) increases recurrence risk. No internal contradictions or missing information prevent selection of a single best answer. The item is logically sound and medically accurate. Minor nuance: some centers may consider alternative fractionation (e.g., 8 Gy×1 or 37.5 Gy/15 fx) based on prognosis, but 30 Gy/10 fx remains the widely accepted standard for this scenario. Overall, the item is a high‑quality, board‑style question.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The question asks which radiotherapy parameter is most critical for optimizing neurological recovery while minimizing toxicity after emergent decompression for metastatic spinal cord compression. The stem provides key details: residual tumor compressing the thecal sac, postoperative deficits, and need for radiotherapy. The correct answer, A (30 Gy in 10 fractions), is the standard dose-fractionation that balances tumor control with spinal cord tolerance, as supported by major guidelines (e.g., NCCN, ASTRO). The alternative choices are clearly inferior: B (limited volume) would miss microscopic disease; C (omitting boost) is not the most critical factor; D (avoiding VEGF inhibitors) is unnecessary because these agents can be continued with dose adjustment; and E (delaying radiation) increases recurrence risk. No internal contradictions or missing information prevent selection of a single best answer. The item is logically sound and medically accurate. Minor nuance: some centers may consider alternative fractionation (e.g., 8 Gy×1 or 37.5 Gy/15 fx) based on prognosis, but 30 Gy/10 fx remains the widely accepted standard for this scenario. Overall, the item is a high‑quality, board‑style question.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-020", "question": "A 58-year-old woman with BRCA2 mutation and bilateral breast cancer s/p bilateral mastectomies presents with isolated sternal metastasis. Biopsy confirms estrogen receptor-positive, HER2-negative adenocarcinoma of breast origin. She receives 30 Gy in 10 fractions to the sternum with good pain relief. Six months later, she develops new biopsy-proven breast cancer metastasis to the right humeral head within the previous radiation field. Which of the following factors most significantly increases the risk of radiation-associated second primary malignancy in this patient?", "options": ["Total radiation dose exceeding 30 Gy", "Concurrent hormonal therapy with aromatase inhibitor", "BRCA2 germline mutation", "Age >50 at time of irradiation", "Use of 3D-conformal rather than intensity-modulated radiotherapy"], "answer": "C", "answer_index": 2, "explanation": "BRCA2 mutations confer deficiency in homologous recombination DNA repair, dramatically increasing sensitivity to ionizing radiation and risk of radiation-induced second malignancies. Dose, technique, and age are minor factors compared to genetic predisposition. Concurrent aromatase inhibitors don't significantly increase radiation carcinogenesis. IMRT may increase low-dose bath but not necessarily secondary malignancy risk. The recurrence in-field is likely a recurrence rather than a radiation-induced second primary, but the question asks specifically about radiation-associated malignancy risk. BRCA2 carriers have 3-5 fold increased risk of radiation-induced cancers compared to non-carriers, mandating careful risk-benefit assessment for radiotherapy.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: Correct best answer. Key stem clues: BRCA2 germline mutation, prior radiation therapy, new lesion within radiation field. The question asks which factor most significantly increases risk of radiation-associated second primary malignancy. BRCA2 deficiency in homologous recombination DNA repair is the dominant risk factor for radiation-induced carcinogenesis, conferring 3-5 fold increased risk versus non-carriers. Alternative options are clearly inferior: dose >30 Gy is irrelevant (patient received exactly 30 Gy) and less impactful than genetic predisposition; aromatase inhibitors do not increase radiation carcinogenesis; age >50 is protective compared to younger age; 3D-conformal technique is not associated with higher second malignancy risk than IMRT. No medical inaccuracies. Minor logical issue: vignette describes a metastasis rather than a radiation-induced second primary, creating conceptual dissonance, but the risk factor question remains clearly answerable. Minimal fix: Revise stem to state 'future risk of radiation-induced second primary malignancy' and clarify the described lesion is metastatic context.\",\n\"medical_accuracy_score\":    \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: BRCA2 germline mutation, prior radiation therapy, new lesion within radiation field. The question asks which factor most significantly increases risk of radiation-associated second primary malignancy. BRCA2 deficiency in homologous recombination DNA repair is the dominant risk factor for radiation-induced carcinogenesis, conferring 3-5 fold increased risk versus non-carriers. Alternative options are clearly inferior: dose >30 Gy is irrelevant (patient received exactly 30 Gy) and less impactful than genetic predisposition; aromatase inhibitors do not increase radiation carcinogenesis; age >50 is protective compared to younger age; 3D-conformal technique is not associated with higher second malignancy risk than IMRT. No medical inaccuracies. Minor logical issue: vignette describes a metastasis rather than a radiation-induced second primary, creating conceptual dissonance, but the risk factor question remains clearly answerable. Minimal fix: Revise stem to state 'future risk of radiation-induced second primary malignancy' and clarify the described lesion is metastatic context.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]